Scoop: AbbVie, Bristol Myers bring out the budget axe, outlining plans to lay off more than 350 West Coast employees
WARN notices in California have shed light on some of the inner workings of biotech and pharma — and newly unveiled notices point at two of the industry’s largest players.
AbbVie and Bristol Myers Squibb separately notified the state earlier this week that they plan on letting go 360 employees combined by the end of November — almost 100 at AbbVie and the rest from Bristol Myers.
AbbVie did not respond to repeated attempts for clarification from Endpoints News.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,600+ biopharma pros reading Endpoints daily — and it's free.